Skip to main content

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials.

Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units). Current Vascular Pharmacology will publish reviews to update all those concerned with the treatment of vascular disease. For example, reviews commenting on recently published trials or new drugs will be included. In addition to clinically relevant topics we will consider 'research-based' reviews dealing with future developments and potential drug targets. Therefore, another function of Current Vascular Pharmacology is to bridge the gap between clinical practice and ongoing research.

Debates will also be encouraged in the correspondence section of this journal.

Publisher: Bentham Science Publishers

Volume 9, Number 3, May 2011

Articles

Free Content Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement
pp. 258-270(13)
Authors: D. Kolovou, Genovefa; P. Mikhailidis, Dimitri; Kovar, Jan; Lairon, Dennis; G. Nordestgaard, Borge; Chye Ooi, Teik; Perez-Martinez, Pablo; Bilianou, Helen; Anagnostopoulou, Katherine; Panotopoulos, George

Favourites:
ADD

Diagnostic Value of Postprandial Triglyceride Testing in Healthy Subjects:A Meta-Analysis
pp. 271-280(10)
Authors: Mihas, Constantinos; D. Kolovou, Genovefa; P. Mikhailidis, Dimitri; Kovar, Jan; Lairon, Dennis; G. Nordestgaard, Borge; Chye Ooi, Teik; Perez-Martinez, Pablo; Bilianou, Helen; Anagnostopoulou, Katherine; Panotopoulos, George

Favourites:
ADD

Clinical Relevance of Non-Fasting and Postprandial Hypertriglyceridemia and Remnant Cholesterol
pp. 281-286(6)
Authors: G. Nordestgaard, Borge; J. Freiberg, Jacob

Favourites:
ADD

Nutrigenetics of the Postprandial Lipoprotein Metabolism: Evidences From Human Intervention Studies
pp. 287-291(5)
Authors: Perez-Martinez, Pablo; Garcia-Rios, Antonio; Delgado-Lista, Javier; Perez-Jimenez, Francisco; Lopez-Miranda, Jose

Favourites:
ADD

Definition of Postprandial Lipaemia
pp. 292-301(10)
Authors: D. Kolovou, Genovefa; P. Mikhailidis, Dimitri; G. Nordestgaard, Borge; Bilianou, Helen; Panotopoulos, George

Favourites:
ADD

Methods to Study Postprandial Lipemia
pp. 302-308(7)
Authors: Chye Ooi, Teik; G. Nordestgaard, Borge

Favourites:
ADD

Effects of Nutrients on Postprandial Lipemia
pp. 309-312(4)
Authors: Lairon, Denis; Defoort, Catherine

Favourites:
ADD

Proposing a “Lipemic Index” As a Nutritional and Research Tool
pp. 313-317(5)
Authors: Chye Ooi, Teik; Robinson, Lindsay; Graham, Terry; D. Kolovou, Genovefa; P. Mikhailidis, Dimitri; Lairon, Denis

Favourites:
ADD

Postprandial Lipemia in Children and Adolescents
pp. 318-320(3)
Authors: D. Kolovou, Genovefa; Bilianou, Helen; P. Mikhailidis, Dimitri

Favourites:
ADD

Effects of Insulin on the Vasculature
pp. 321-332(12)
Authors: M. Breen, Danna; Giacca, Adria

Favourites:
ADD

Hypoxia-Inducible Factor-1 in Arterial Disease: A Putative Therapeutic Target
pp. 333-349(17)
Authors: Kasivisvanathan, Veeru; Shalhoub, Joseph; S. Lim, Chung; C. Shepherd, Amanda; Thapar, Ankur; H. Davies, Alun

Favourites:
ADD

Update on Pharmacologic Approaches to Prevent Thromboembolism in Atrial Fibrillation: Are Thrombin and Factor Xa Inhibitors the Ultimate Answer?
pp. 350-357(8)
Authors: Wolfram, Oliver; Hammwoehner, Matthias; Gramley, Felix; Goette, Andreas

Favourites:
ADD

The Emerging Role of Vascular Endothelial Growth Factor (VEGF) in Vascular Homeostasis: Lessons from Recent Trials with Anti-VEGF Drugs
pp. 358-380(23)
Authors: Thanigaimani, Shivshankar; Kichenadasse, Ganessan; A. Mangoni, Arduino

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more